This double-blind, randomized, sham-controlled clinical trial aims to evaluate the effects of vascular photobiomodulation on blood pressure and vascular function in hypertensive patients treated with losartan. A total of 80 patients using losartan (100 mg/day for at least two months) will be recruited and followed for 4 weeks. Participants will be randomly allocated to either an active photobiomodulation group or a sham control group.
Patient in use of losartan at a dose of 100 mg/day divided into two doses as the only antihypertensive medication, for a minimum of 2 months.
Present systolic blood pressure is less than or equal to 140 mmHg and diastolic less than or equal to 90 mmHg.
Not having used any other antihypertensive medication in the last 2 months.
Age between 18 and 65 years
Changes in medication status during the study